Buy Natco Pharma Ltd. with a target of Rs 750 – Kotak Securities Limited
Buy Natco Pharma Ltd. with a target of Rs 750. The stock, Kotak Securities believes will continue to trade at higher multiples given the events lined up over the next 6-12 months.
Kotak Securities says Strong R&D capabilities and focus on creating a niche product portfolio sets Natco apart from its peers. For the coming years we expect both US and domestic formula tions to further lead the growth and enable the company in posting 58% revenue CAGR and 87% PAT CAGR over FY15-18E. The stock Kotak Securities believes will continue to trade at higher multiples given the events lined up over the next 6-12 months.
Download ET Markets APP